Skip to main content

Table 1 Baseline characteristic of patients with ICG-R15 ≥ 10% or ICG-R15 < 10%

From: The technique of 3D reconstruction combining with biochemistry to build an equivalent formula of indocyanine green (ICG) clearance test to assess the liver reserve function

Before propensity matching After propensity matching
   ≥ 10% (n = 97) < 10% (n = 203) p-value  ≥ 10% (n = 58) < 10% (n = 58) p-value
Age (Y) 55.57 ± 11.12 51.68 ± 12.24 0.009* 55.07 ± 11.65 54.09 ± 12.03 0.656
Sex (male, %) 72 (74.23%) 167 (82.27%) 0.106 45 (77.59%) 52 (89.66%) 0.079
BMI 23.39 ± 3.24 22.93 ± 3.07 0.232 23.53 ± 3.31 22.55 ± 3.39 0.117
HGB (g/L) 128.52 ± 25.66 138.49 ± 23.92 0.001* 131.76 ± 28.53 134.57 ± 25.56 0.578
WBC(× 109 /L) 4.96 ± 2.54 5.72 ± 1.86 0.005* 5.37 ± 2.81 5.41 ± 2.03 0.928
PLT (× 109 /L) 112.62 ± 72.50 153.88 ± 76.22  < 0.001* 122.19 ± 60.93 138.29 ± 77.14 0.215
HBV (positive, %) 77 (79.38%) 145 (71.43%) 0.241 48 (82.76%) 41 (70.69%) 0.125
Tb (μmol/L) 23.58 ± 12.90 15.88 ± 7.81  < 0.001* 18.80 ± 9.44 19.47 ± 10.32 0.716
AST (median IU/L) 56.0 (39.0–74.0) 42.0 (27.0–62.0)  < 0.001* 49.00 (37.75–71.75) 52.50 (32.50–71.05) 0.722
ALT (median IU/L) 45.0 (27.0–71.0) 39.0 (22.0–60.0) 0.030* 41.50 (27.00–55.25) 44.50 (21.75–84.25) 0.647
ALB (g/L) 36.8 ± 4.85 41.12 ± 4.38  < 0.001* 38.25 ± 4.61 38.15 ± 3.99 0.897
PT(s) 12.28 ± 1.12 12.59 ± 1.49 0.071 12.64 ± 1.40 12.57 ± 1.11 0.753
TV (mL) 78.9 (22.49–386.29) 130.(45.99–405.99) 0.137 88.86 (25.25–451.53) 156 (81.04–611.76) 0.107
RLV (mL) 1152.65 ± 358.80 1121.30 ± 268.05 0.398 1128.72 ± 292.35 1122.33 ± 326.21 0.912
SV (mL) 471.57 ± 282.31 284.12 ± 180.39  < 0.001* 414.41 ± 210.77 324.82 ± 206.34 0.023*
BSA 1.66 (1.55–1.75) 1.65 (1.53–1.77) 0.797 1.67 (1.58–1.76) 1.63 (1.52–1.77) 0.344
SNLV 703.85 ± 215.92 673.60 ± 140.22 0.147 689.79 ± 167.03 676.81 ± 166.46 0.805
SNLR 0.44 ± 0.29 0.26 ± 0.16  < 0.001* 0.38 ± 0.22 0.30 ± 0.18 0.029*
  1. * Reflecting the difference was significant in statistics (p < 0.05)